Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
gptkb:subsidiary |
| gptkbp:abbreviation |
gptkb:CNBG
|
| gptkbp:country |
gptkb:China
|
| gptkbp:developedBy |
gptkb:Sinopharm_WIBP_COVID-19_vaccine
gptkb:BBIBP-CorV |
| gptkbp:founded |
1919
|
| gptkbp:headquartersLocation |
gptkb:Beijing
|
| https://www.w3.org/2000/01/rdf-schema#label |
China National Biotec Group
|
| gptkbp:industry |
gptkb:biotechnology
pharmaceuticals |
| gptkbp:notableWork |
COVID-19 vaccine development
polio vaccine hepatitis B vaccine |
| gptkbp:parentCompany |
gptkb:Sinopharm
|
| gptkbp:product |
vaccine
vaccines biopharmaceuticals |
| gptkbp:subsidiary |
gptkb:Sinopharm_Group
|
| gptkbp:website |
http://www.cnbg.com.cn/
|
| gptkbp:bfsParent |
gptkb:China_National_Pharmaceutical_Group
|
| gptkbp:bfsLayer |
6
|